Tarsus Pharmaceuticals Inc.

TARS | NASDAQ

Price Alert Chart Builder DCF Calculator

$77.46

-$0.63 (-0.81%)

At close: Sep 21, 2026, 4:00 PM ET

$77.46

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-66.42M	-115.55M	-135.89M	-62.09M	-13.83M	-26.81M
Depreciation & Amortization	1.82M	1.23M	877K	325K	312K	96K
Stock-Based Compensation	41.72M	27.82M	19.83M	13.46M	8.46M	839K
Other Working Capital	48.53M	-4.31M	4.3M	-1.77M	-2.44M	-1.8M
Other Non-Cash Items	-4.21M	-360K	-2.61M	227K	7.44M	3.28M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	14.64M	3.84M	306K	-951K	1.37M	1.46M
Operating Cash Flow	-12.45M	-83.03M	-117.49M	-49.03M	3.75M	-21.14M
Capital Expenditures	-9.86M	-1.57M	-5.5M	-506K	-586K	-456K
Cash Acquisitions	n/a	n/a	n/a	144.12M	n/a	n/a
Purchase of Investments	-394.06M	-265.63M	-28.66M	-149.44M	n/a	n/a
Sales Maturities Of Investments	361.8M	73M	174.77M	5.32M	n/a	n/a
Other Investing Acitivies	n/a	-5M	-4M	-144.12M	n/a	n/a
Investing Cash Flow	-42.12M	-199.2M	140.6M	-144.63M	-586K	-456K
Debt Repayment	n/a	39.6M	10M	19.13M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	-28K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a	n/a	n/a	370K
Financial Cash Flow	143.39M	154.66M	130.18M	93.99M	21K	131.77M
Net Cash Flow	88.82M	-127.57M	153.29M	-99.67M	3.18M	110.18M
Free Cash Flow	-22.31M	-84.59M	-123M	-49.54M	3.16M	-21.59M
Adj. Free Cash Flow	-64.03M	-112.41M	-142.83M	-63M	-5.29M	-22.43M
Maintenance CapEx	n/a	n/a	-5.5M	-506K	n/a	-96K
Growth CapEx	-9.86M	-1.57M	n/a	n/a	-586K	-360K
Owner Earnings	-12.45M	-83.03M	-123M	-49.54M	3.75M	-21.23M